• Janssen submits MAA to EMA for esketamine nasal spray pharmaceutical-technology
    October 12, 2018
    Johnson & Johnson’s Janssen Pharmaceutical Companies has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for its esketamine nasal spray.
PharmaSources Customer Service